 Tacrolimus
"Tacrolimus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro.
| Descriptor ID |
D016559
|
| MeSH Number(s) |
D02.540.505.810
|
| Concept/Terms |
Anhydrous Tacrolimus- Anhydrous Tacrolimus
- Tacrolimus, Anhydrous
- Tacrolimus Anhydrous
- Anhydrous, Tacrolimus
|
Below are MeSH descriptors whose meaning is more general than "Tacrolimus".
Below are MeSH descriptors whose meaning is more specific than "Tacrolimus".
This graph shows the total number of publications written about "Tacrolimus" by people in this website by year, and whether "Tacrolimus" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 5 | 4 | 9 | | 1992 | 2 | 0 | 2 | | 1993 | 0 | 2 | 2 | | 1994 | 2 | 0 | 2 | | 1995 | 6 | 0 | 6 | | 1996 | 6 | 1 | 7 | | 1997 | 3 | 2 | 5 | | 1998 | 1 | 0 | 1 | | 1999 | 0 | 1 | 1 | | 2000 | 2 | 0 | 2 | | 2001 | 5 | 3 | 8 | | 2002 | 3 | 2 | 5 | | 2003 | 3 | 4 | 7 | | 2004 | 4 | 2 | 6 | | 2005 | 9 | 3 | 12 | | 2006 | 2 | 0 | 2 | | 2007 | 3 | 2 | 5 | | 2008 | 3 | 2 | 5 | | 2009 | 4 | 1 | 5 | | 2010 | 3 | 2 | 5 | | 2011 | 3 | 4 | 7 | | 2012 | 2 | 0 | 2 | | 2013 | 6 | 2 | 8 | | 2014 | 4 | 3 | 7 | | 2015 | 5 | 0 | 5 | | 2016 | 2 | 2 | 4 | | 2017 | 5 | 0 | 5 | | 2018 | 2 | 0 | 2 | | 2019 | 4 | 1 | 5 | | 2020 | 2 | 0 | 2 | | 2021 | 1 | 3 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Tacrolimus" by people in Profiles.
-
Boehm M, Tian X, Ali MK, Mao Y, Ichimura K, Zhao M, Kuramoto K, Dannewitz Prosseda S, Fajardo G, Dufva MJ, Qin X, Kheyfets VO, Bernstein D, Reddy S, Metzger RJ, Zamanian RT, Haddad F, Spiekerkoetter E. Improving Right Ventricular Function by Increasing BMP Signaling with FK506. Am J Respir Cell Mol Biol. 2021 09; 65(3):272-287.
-
Campbell KR, Martins R, Davis S, Juarez-Colunga E. Dynamic prediction based on variability of a longitudinal biomarker. BMC Med Res Methodol. 2021 05 15; 21(1):104.
-
Kemme S, Stahl M, Brigham D, Lovell MA, Nakano T, Feldman AG, Mack C. Outcomes of Severe Seronegative Hepatitis-associated Aplastic Anemia: A Pediatric Case Series. J Pediatr Gastroenterol Nutr. 2021 02 01; 72(2):194-201.
-
Hardesty A, Pandita A, Vieira K, Rogers R, Merhi B, Osband AJ, Aridi J, Shi Y, Bayliss G, Cosgrove C, Gohh R, Morrissey P, Beckwith CG, Farmakiotis D. Coronavirus Disease 2019 in Kidney Transplant Recipients: Single-Center Experience and Case-Control Study. Transplant Proc. 2021 May; 53(4):1187-1193.
-
Cheung AY, Sarnicola E, Eslani M, Wright E, Goebel J, Hooper DK, Govil A, Kurji KH, Holland EJ. Clinical Outcomes of Allogeneic Ocular Surface Stem Cell Transplantation in Pediatric Patients. Cornea. 2021 Jan; 40(1):54-60.
-
Davis S, Wiebe C, Campbell K, Anobile C, Aubrey M, Stites E, Grafals M, Pomfret E, Nickerson P, Cooper JE. Adequate tacrolimus exposure modulates the impact of HLA class II molecular mismatch: a validation study in an American cohort. Am J Transplant. 2021 01; 21(1):322-328.
-
Zuhra K, Augsburger F, Majtan T, Szabo C. Cystathionine-ß-Synthase: Molecular Regulation and Pharmacological Inhibition. Biomolecules. 2020 04 30; 10(5).
-
Davis S, Gralla J, Klem P, Stites E, Wiseman A, Cooper JE. Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor-Specific Antibodies. Transplantation. 2020 04; 104(4):881-887.
-
Campbell KR, Juarez-Colunga E, Grunwald GK, Cooper J, Davis S, Gralla J. Comparison of a time-varying covariate model and a joint model of time-to-event outcomes in the presence of measurement error and interval censoring: application to kidney transplantation. BMC Med Res Methodol. 2019 06 26; 19(1):130.
-
Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millán O, Mizuno T, Moes DAR, Monchaud C, Noceti O, Pawinski T, Picard N, van Schaik R, Sommerer C, Vethe NT, de Winter B, Christians U, Bergan S. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report. Ther Drug Monit. 2019 06; 41(3):261-307.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|